Papillomaviruses appear to be species-specific pathogens, and it was suggested that each animal species might harbour its own set of papillomaviruses. However, all approaches addressing the underlying evolutionary phenomena still suffer from very limited data about animal papillomaviruses. In case of the horse for example, only three equine papillomaviruses (EcPVs) have been identified. To further address the situation in this host, suspected papillomavirusassociated lesions were tested for EcPV DNA. Four novel EcPV types were detected and their genomes entirely cloned and sequenced. They display the characteristic organization, with early (E) and late (L) regions harbouring the seven classical open reading frames divided by non-coding regions. They were named EcPVs 4, 5, 6 and 7, according to their dissimilarity to other papillomaviruses. Most L1 nucleotide identities were shared with EcPV2 in case of EcPV4 (62 %) and EcPV5 (60 %) or with EcPV3 in case of EcPV6 (70 %) and EcPV7 (71 %). Thus, EcPVs 4 and 5 may establish novel species within the genus Dyoiota, while EcPVs 6 and 7 might fit into the genus Dyorho and belong to the same species as EcPV3. They were found in genital plaques (EcPV4), aural plaques (EcPV5, EcPV6) or penile masses (EcPV7). Interestingly, PCR analysis revealed the DNA of EcPV2 and EcPV4 as well as of EcPV3 and EcPV6 together in the same tissue samples, respectively. In conclusion, the DNA of four novel EcPV types was identified and cloned. They cluster with the known types and support broad genetic EcPV diversity in at least two of the known clades. Furthermore, PCR assays also provide evidence for EcPV co-infections in horses.
INTRODUCTION
The Papillomaviridae family, which has been established as an independent one, separated from the Polyomaviridae family 12 years ago, is rapidly growing, as new putative members are frequently discovered. Their members, the Papillomaviruses (PVs), have a characteristic circular double stranded DNA genome of around eight kilobase pairs (kbp) that usually contains at least six relatively conserved open reading frames (ORFs) in an early (E1, E2, E6, E7) and a late (L1, L2) region. The DNA of the PVs is contained in icosahedral capsids mainly composed of 72 L1 pentamers with a total diameter of approximately 50 nm (Howley & Lowy, 2007) . The Papillomaviridae family is considered as evolutionary very old, as there is a very high genetic diversity among PVs and several animal species have been shown to harbour their own set of PV types. The diversity is revealed in phylogenetic analyses and by 2010 almost 200 PV types had been recognized (Bernard et al., 2010) . Almost two-thirds of these so far known PV types infect humans, but the number of animal PV discoveries is increasing. The suspected overrepresentation of human PVs in many analyses looking at the phylogeny of PVs has led to different models that are somewhat contradictory (Rector et al., 2007; Bravo et al., 2010) . The main obstacle in finding solid ground for a broadly acceptable hypothesis about PV evolution is the very poor resolution outside the human PV genera Alpha, Beta and Gamma.
To classify novel PVs, the DNA sequence of the relatively conserved L1 ORF is compared with the known sequences and accordingly assigned to a genus and species as being a new type, subtype or variant. The criteria for this assignment define genus distinction as below 60 % identity and species distinction as below 70 % identity. Novel types have to differ by at least 10 % and subtypes by no less than 2 %, while smaller differences characterize variants (de Villiers et al., 2004; Bernard et al., 2010) . Although this classification does not take into account putative evolutionary differences of the different PV genes or clinical aspects of PV infections, it establishes a viable taxonomic system (de Villiers et al., 2004; Gottschling et al., 2011) .
The effects and the impact of PV infections on individuals as well as on public health in general have been partly revealed in the past decade, with human PVs (HPVs) being in the focus of most efforts. HPVs have been demonstrated to contribute to various benign as well as malignant transformations of epithelial cells, while it was also discovered that apparently subclinical infections are very frequent (zur Hausen 1996; Antonsson et al., 2000; Howley & Lowy, 2007) . Far less is indeed known about PV infections and their effects in animals. Thus, by far the best studied animal PV infections include those of domestic animals, which is partly reflected in the number of types known to infect those species, namely 14 in dogs, 12 in cattle, 5 in horses (BPV1, BPV2, EcPV1, EcPV2, EcPV3), 3 in sheep and 2 in cats. In this context, the horse has a rather prominent role. Although PVs are generally regarded as species-specific, horses can be infected not only by equine, but also by bovine PVs (BPVs) (Scott & Miller, 2003; Bogaert et al., 2008; Nasir & Campo, 2008) . While the infections with BPV1 and BPV2 in horses have been a focus of some research for quite a while, actual equine PVs (EcPVs) were not a big issue until a few years ago. Until now, three EcPVs have been described, sequenced and cloned in their entirety. They all seem to be associated with distinct pathologies. EcPV1 has been isolated from 'classical equine papillomas', a typical benign neoplasia of young horses that is usually transient (O'banion et al., 1986; Scott & Miller, 2003; Ghim et al., 2004; Postey et al., 2007) . The DNA of EcPV2 has been found in both benign and malignant genital neoplasias, and has been repeatedly detected in recent years. The data suggest that EcPV2 DNA may indeed be involved in the development of these disorders; although EcPV2 can also be detected in some other equine tumours, in semen and on clinically unaffected skin (Scase et al., 2010; Knight et al., 2011a, b; Lange et al., 2011a Lange et al., , 2012 Bogaert et al., 2012; Kainzbauer et al., 2012; Sykora et al., 2012) . The third one, EcPV3, has been detected in equine aural plaques that had also previously been suggested to be PV-associated (Fairley & Haines, 1992; Postey et al., 2007; Lange et al., 2011a) . These three EcPV types do represent three different PV genera, namely Zeta, Dyoiota and Dyorho. There is also strong evidence for the existence of a fourth EcPV that has been partially sequenced (Taniwaki et al., 2013) . The lack of closely related PVs makes a profound phylogenetic allocation of these EcPVs difficult. This study was initiated to improve the knowledge regarding PV phylogeny, to challenge the hypothesis that EcPVs may potentially be as diverse as bovine, canine and maybe human PVs and to find out more about potential involvements in the development of skin disorders.
RESULTS

PCR and rolling circle analysis (RCA)
One of the easiest and most sensitive methods to determine a putative PV association with any type of lesion is classical PCR. Three PCR assays for PV DNA and one for host DNA were therefore applied in all included cases. Host DNA was amplified in all the samples taken (Table 1) . In cases no. 1 (vulval plaques) and no. 2 (penile and inguinal plaques), DNA was amplified with the FAP59/FAP64 and with the EcPV2probe f/r assays; sequencing revealed EcPV2 DNA as well as the DNA of a thus far unknown PV type. FAP59/ FAP64 PCR revealed a different and also previously not described PV DNA in case no. 3 (aural plaques). In the samples obtained from case no. 4 (aural plaques), CP4/CP5 PCR amplified EcPV3 DNA from one ear and a different undetermined PV DNA from the other, while it amplified EcPV3 DNA in both with the WeF03/WeR09 PCR. CP4/ CP5 PCR also amplified a novel PV DNA in the samples from case no. 5 (penile masses). No indication of the presence of HPV DNA was found in any of the cases. Samples containing unknown PV DNA were additionally tested using RCA. The RCA analysis indicated circular DNA of about eight thousand nucleotides in all these tested samples, whereas the restriction analysis of the RCA products produced patterns unlike any known EcPVs or BPVs. To determine the sequences in detail, they were cloned and sequenced. The nucleotide sequences were deposited in GenBank under accession numbers JQ031032 (EcPV4), JQ031033 (EcPV5), JQ965698 (EcPV6) and JX035935 (EcPV7).
Genomes and open reading frames
The genomes of PVs contain usually around 8 kbp and have a genomic organization that typically displays seven or eight ORFs as well as one or two non-coding regions (NCRs) (Howley & Lowy, 2007) . The genome sizes of the four cloned novel EcPVs were found to be very similar. The genome of EcPV4 consists of 7554 bp, EcPV5 of 7519 bp, EcPV6 of 7551 bp and EcPV7 of 7619 bp. The GC contents are 55 % for the EcPV4 genome, 50 % for the EcPV5 genome, 51 % for the EcPV6 genome and 52 % for the EcPV7 genome. Seven characteristic ORFs were identified in all four novel EcPV genomes (Fig. 1) . The ORFs encoding the late PV genes appear to be quite conserved regarding their size. The greatest variation among the EcPVs was observed among the early genes E6 and E7. The E4 ORF, which usually lacks its own start codon, varied among the viruses, and therefore could not be predicted with certainty.
Characteristic motifs
Several characteristic features on the nucleotide and amino acid levels have been proposed and predicted to play a role in the PV life cycle (Androphy et al., 1987; Wilson et al., 2002; Münger et al., 2004; Howley & Lowy, 2007) . The genomes of the four novel EcPV candidates were scanned to identify such putative sites and the analysis revealed typical features in all of them (Table 2) . Dyad symmetry repeats, a variable number of putative E2 binding sites and at least one polyadenylation signal were present on every EcPV sequence. Sp1 and Nf1 binding sites could be predicted in all EcPVs, AP1 was found in all but EcPV4 and at least one classical TATA box was seen in all but EcPV2 (Table 2a) . Examination of the putative protein sequences revealed ATP-dependent helicase motifs in the E1 protein sequence of all EcPVs, but they were modified in the four novel ones. Putative metal-binding motifs were present in all E6 (2) and E7 (1) amino acid sequences. Leucine zipper domains were only found in the E1 of EcPV3, EcPV6 and EcPV7 as well as in the E2 of EcPV2 and EcPV4 (Table 2b) .
Sequence analysis and comparison
To allocate the novel EcPVs, a phylogenetic analysis based on the aligned E1-E2-L2-L1 sequences was performed. For that purpose the sequences of the eight different EcPV types or isolates as well as 42 other PVs, representing all presently classified genera were aligned (Fig. 2) . The EcPVs were found to cluster together with the Delta PVs with limited support of the branching by the posterior For a putative taxonomic classification of the four novel PV isolates according to the present guidelines of PV classification (de Villiers et al., 2004; Bernard et al., 2010) , pairwise alignments of the L1 nucleotide sequences were performed. EcPV4 was found to share most identities with EcPV5 (65 %) and the two EcPV2 variants (62 %). The L1 was also found to match a partial PV sequence described previously (Taniwaki et al., 2013) . EcPV5 at the same time apparently shares more identities with EcPV2a (62 %) than with EcPV2b (60 %). EcPV6 and EcPV7 share most identities with each other (71 %) and with EcPV3 (70 %). All six obvious ORFs were analysed in the same manner on the predicted amino acid level (Table S1 , available in JGV Online). Overall, the highest identities were among the sequences of EcPVs 3, 6 and 7, whereas EcPVs 4 and 5, although closest to each other, shared significantly fewer identities. The only exception was the E6 sequence. In case of E6, the identities between EcPVs 3, 6 and 7 were comparable to those between EcPVs 4 and 5. Consequently EcPV4 and EcPV5 may be regarded as representing two novel species within the genus Dyoiota, whereas EcPV6 and EcPV7 seem to belong to the same species as EcPV3 within the genus Dyorho.
DISCUSSION
The number of known family members within the Papillomaviridae is constantly growing. However, while still more than half of the PVs described have been associated with human hosts, more and more newly discovered animal PVs are starting to alter our view of PV phylogeny and evolution. It appears that many if not all host species may harbour their own set of PV types that belong to a few distinct genera. For the HPVs five such genera are currently recognized containing all of the more than 150 defined types and isolates (de Villiers et al., 2004; Bernard et al., 2010; Kovanda et al., 2011) . Analogous to that, the bovine and canine PVs for example, have been assigned to three genera each (Bernard et al., 2010) . The same is true for the EcPVs. The four novel PV sequences described here support this hypothesis, as they cluster closely with the few known types within the three defined genera. Upon phylogenetic analysis, the three EcPV genera cluster together with each other and with the Delta PVs. This is an interesting observation, as BPV1 and BPV2, although classified as bovine PVs, also infect and cause disease in horses and belong to this genus. However, the statistical support for this clade formation is rather weak, and we probably still know only very few (too few) of the circulating animal PVs. Thus drawing conclusions from that would probably be premature. Finding and sequencing additional PV candidates may shed more light on these evolutionary and pathobiologically interesting issues.
As the taxonomic classification of PVs is formally based on the L1 nucleotide sequence, the four novel EcPVs could easily be assigned to the relatively novel genera Dyoiota and Dyorho. In addition, they may be further classified into species within the genera. According to their L1 nucleotide sequences, EcPV6 and EcPV7 may belong to the same species as EcPV3 within Dyorho. EcPV4 and EcPV5 however, although within Dyoiota like EcPV2, appear to represent two novel species within that genus. This is also supported by the pairwise comparison of the other individual ORFs, which except for E6, showed markedly more identities among the three Dyorho PVs than among the Dyoiota PVs (Table S1 ). The results of the phylogenetic analysis also point in the same direction. The definitive classification, however, is a matter of the International Committee on Taxonomy of Viruses (ICTV) and the ICTV papillomavirus study group, respectively. Interestingly, there seems to be no correlation between genus and genome size among the EcPVs, whereas that seems to be the case with the HPVs (Alpha.Beta.Gamma), the BPVs (Delta.Epsilon.Xi) and the CPVs (Lambda.Tau.Chi) (Lange et al., 2009) .
Previous studies have shown that although HPV DNA is not very abundant on the skin of healthy individuals, the same host may be infected with or carry more than one PV type at the same time. The results of this study clearly indicate that this is the case in horses as well. In cases no. 1 and 2, EcPV2 DNA was detected in the same host and the (Kainzbauer et al., 2012; Lange et al., 2012) .
One of the most interesting and thus often very controversially discussed questions about PVs is their potential role in the pathogenesis of various neoplastic disorders. The four EcPVs described here were all extracted from cytobrush samples of lesions that had been suspected to be PV-associated, namely penile neoplasias, aural plaques and depigmented genital and inguinal plaques. Since no biopsy samples could be taken from any of these cases, it is not possible to determine whether any of the four new EcPVs actually played any role in the observed pathologies.
In conclusion, four novel EcPVs were discovered and genetically and phylogenetically analysed and characterized. The results support the clustering of EcPVs into the three established genera, confirm infections with more than one PV in horses and warrant further research regarding the possible pathogenicity and involved mechanisms.
METHODS
Samples. For this study, samples were obtained from five horses that were patients of the veterinary teaching hospital of the Vetsuisse Faculty of the University of Zurich. Inclusion criteria were a suspected diagnosis of PV infection and PCR or RCA results indicating PV DNA of an unknown type. These included one Westfalian mare with white vulval plaques, a Friesian stallion with white inguinal plaques, an Arabian gelding with aural plaques, a German warmblood gelding with aural plaques and an Irish warmblood gelding with penile masses (Table 1) . Testing material was acquired with cytobrushes that were moistened with sterile 0.9 % NaCl solution, gently rubbed for 30 s on putatively PV-associated skin alterations and stored in a 1.5 ml Eppendorf tube at 220 uC until DNA extraction.
Identification, amplification and cloning of genomes. DNA was isolated from the cytobrush samples using a DNeasy extraction kit (Qiagen). The protocol was slightly modified to meet the specific needs, namely the volume of all buffers used prior to the loading of the column was doubled to ensure the brush was covered with liquid. The elution buffer was used sparsely (100 ml in total) to increase the DNA concentration in the eluate. For initial identification of host and PV DNA in the samples, ecGAPDH f (GAG CTG AAT GGG AAG CTC AC)/ecGAPDH r (CTG AGG GCC TTT CTC CTT CT), CP4/ CP5, FAP59/FAP64, EcPV2probe f/r and WeF03 (TCT GGG TAG CCG CAA ATA TC)/WeR09 (GCA CCT GAG GTC CTA TCT GG) PCR assays were applied (Forslund et al., 1999; Iftner et al., 2003; Lange et al., 2012) . The protocols were applied as described, and in case of the ecGAPDH f/r and WeF03/WeR09 primers, the same conditions as for the EcPV2probe f/r were applied (Lange et al., 2011b (Lange et al., , 2012 . PCR products were determined (Microsynth) by cycle sequencing using an ABI 377 sequencer (Applied Biosystems) and compared to the NCBI database (BLASTX). For the purpose of cloning, 1 ml of the DNA extract was used for RCA , using a TempliPhi Amplification kit (General Electrics Biosciences). Slight modifications were applied to the protocol supplied by the manufacturer (Lange et al., 2009) . Amplified PV DNA was cloned into the BamHI, ClaI, EcoRI and HinDIII sites of pBluescript II KS+ (Stratagene) (from cases no. 1 and no. 2; EcPV4), into the HinDIII and XbaI sites (from case no. 3; EcPV5), into the BamHI site (from case no. 4; EcPV6) or into the BamHI and EcoRI sites (from case no. 5; EcPV7), using standard procedures. The cloned DNA sequences of the PV candidates were determined (Microsynth), and primary sequences were assembled using Contigexpress software (Vector NTI Informax, Invitrogen). The names of the viruses and genera were approved by the papillomavirus study group of the ICTV.
Sequencing analysis. The coding sequences for the E6, E7, E1, E2, L2 and L1 proteins of the four novel EcPVs were compared with previously published PV sequences including: Moose (Alces alces) AaPV1 (M15953); bovine (Bos primigenius) BPV1 (X02346), BPV3 (NC_004197), BPV5 (AF457465), BPV7 (NC_007612); marine turtles Caretta caretta CcPV1 (EU493092) and Chelonia mydas CmPV1 (EU493091); caprine (Capra hircus) ChPV1 (NC_008032); canine
